A carregar...
抗CD19 CAR-T细胞序贯异基因造血干细胞移植术治疗难治B淋巴细胞白血病疗效及安全性观察
OBJECTIVE: To investigate the efficacy and side effects of anti-CD19 CAR-T cell bridging to allogeneic hematopoietic stem cell transplantation （allo-HSCT） regimen for refractory Blymphoblastic leukemia. METHODS: 10 patients with refractory B-lymphoblastic leukemia with minimal residual disease（MRD）n...
Na minha lista:
| Publicado no: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Editorial office of Chinese Journal of Hematology
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7357920/ https://ncbi.nlm.nih.gov/pubmed/32311895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.03.010 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|